Archivio per categoria: Anno

, , , , , , , , , , ,

Interprofessional collaborative practice is strong in young health professionals: evidence from an Italian Winter School attended by hospital pharmacists and internal medicine physicians

Continua a leggere
, , , , , , , , , , ,

Treatments for Relapsed-Refractory Diffuse Large B-cell Lymphoma: A Preliminary Evaluation of the Place in Therapy of Glofitamab, a Bispecific Monoclonal Antibody

Continua a leggere
, , , , , , , , , , , , , , ,

Application of the IPDfromKM-Shiny Method to Compare the Efficacy of Novel Treatments Aimed at the Same Disease Condition: A Report of 14 Analyses

Continua a leggere
, , , , , , , , , , , ,

Progression-Free and Overall Survival of First-Line Treatments for Advanced Renal Cell Carcinoma: Indirect Comparison of Six Combination Regimens

Continua a leggere
, , , , , , , , , , , ,

Survival with novel hormonal therapies in patients with nonmetastatic castration-resistant prostate cancer: indirect comparison of three randomized phase-III trials.

Continua a leggere
, , , , , , , , , , , , ,

The “One-to-Many” Survival Analysis to Evaluate a New Treatment in Comparison With Therapeutic Alternatives Based on Reconstructed Patient Data: Enfortumab Vedotin Versus Standard of Care in Advanced or Metastatic Urothelial Carcinoma.

Continua a leggere
, , , , , , , , , , , , , ,

Application of artificial intelligence for an early comparison of efficacy between new cancer drugs

Continua a leggere
, , , , , , , ,

Chimeric Antigen Receptor T Cells in Large B-Cell Lymphoma: Analysis of Overall Survival Based on Reconstructed Patient-Level Data

Continua a leggere
, , , , , , , , , , , ,

Survival in Patients with Relapsed-Refractory Multiple Myeloma: Indirect Comparison of Six New Treatments

Continua a leggere
, , , , , , , , , , , ,

Immune checkpoint inhibitors as first line in advanced melanoma: Evaluating progression-free survival based on reconstructed individual patient data

Continua a leggere